All-poly Versus Metal-backed

Sponsor
Region Skane (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04358601
Collaborator
(none)
60
2
120

Study Details

Study Description

Brief Summary

The primary objective is the assessment of prosthetic migration results after two years of the Triathlon PS Knee System with all-polyethylene tibial components compared to the Triathlon PS Knee System with metal-backed modular components by means of Roentgen Stereophotogrammetry.

Condition or Disease Intervention/Treatment Phase
  • Device: Triathlon PS Knee System with all-polyethylene tibial components
  • Device: Triathlon PS Knee System with metal-backed modular components
N/A

Detailed Description

The secondary objective will be the prediction of the long-term survival based on the two-year migration patterns combined with clinical factors and radiographic aspects. In order to identify other clinical parameters besides the fixation of the prosthesis components, clinical scores and radiographic aspects will be correlated with the RSA outcome.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Primary Purpose:
Treatment
Official Title:
Migration and Survival of All-polyethylene Tibial Components Compared to the Metal-backed Modular Components of the Triathlon PS Total Knee System. A RSA Study
Actual Study Start Date :
Nov 1, 2014
Actual Primary Completion Date :
Sep 17, 2017
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: All-polyethylene tibial components

Triathlon PS Knee System with all-polyethylene tibial components

Device: Triathlon PS Knee System with all-polyethylene tibial components
Primary Total Knee Replacement
Other Names:
  • Stryker Orthopaedics
  • Active Comparator: Metal-backed modular components

    Triathlon PS Knee System with metal-backed modular components

    Device: Triathlon PS Knee System with metal-backed modular components
    Primary Total Knee Replacement
    Other Names:
  • Stryker Orthopaedics
  • Outcome Measures

    Primary Outcome Measures

    1. Migration, measured by means of RSA [2 years]

      Migration (MTPM in mm) of the prosthesis with respect to the host bone measured by means of roentgen stereophotogrammetric analysis (RSA)

    Secondary Outcome Measures

    1. Migration, measured by means of RSA [10 years]

      Migration (MTPM in mm) of the prosthesis with respect to the host bone measured by means of roentgen stereophotogrammetric analysis (RSA)

    2. Investigation of clinical performance and patient outcome with the Knee Society Score (KSS) [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

      The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.

    3. Investigation of clinical performance and patient outcome with the Knee Injury and Osteoarthritis Outcome Score (KOOS) patient questionnaire [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

      KOOS consists of 5 subscales: Pain, other symptoms, function in daily living , function in sport and recreation and knee related quality of life (QOL). The previous week is the time period considered when answering the questions. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms).

    4. Investigation of clinical performance and patient outcome with EuroQuol-5 dimension (EQ-5D) patient questionnaire [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

      The EQ-5D health questionnaire provides a simple descriptive profile and a single index value for health status.

    5. Investigation of clinical performance and patient outcome with the Forgotten Joint Score (FJS) patient questionnaire. [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

      The FJS consists of 12 questions and focuses on the patients' awareness of their joint replacement during a range of day to day and recreational activities. The score has a range of 0-100.questionnaire

    6. Investigation of patient outcome with radiographic analysis [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

      Plain radiographs will be obtained for assessment of fixation of the device.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    1. The subject is morbidly obese, defined as Body Mass Index (BMI) of > 40. 2. Patient has a flexion contracture of 15° and more. 3. Patient has a varus/valgus contracture of 15° and more. 4. Patients with a pre-operative knee score of >70. 5. The subject has a history of total or unicompartmental reconstruction of the affected joint. 6. The subject will be operated bilaterally. 7. Patients who had a Total Hip Arthroplasty (THA) on contralateral and/or ipsilateral side within the last year that is considered to have an unsatisfactory outcome (Patients with contralateral and/or ipsilateral THA > 1 year ago with good outcome can be included in the study). 8. Patients who had a Total Knee Arthroplasty (TKA) on contralateral side within the last 6 months that is considered to have an unsatisfactory outcome. (Patients with contralateral TKA > 6 months ago with good outcome can be included in the study). 9. The subject has an active or suspected latent infection in or about the knee joint. 10. Osteomyelitis 11. Sepsis 12. Patient who is expected to need lower limb joint replacement for another joint within one year. 13. The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device. 14. The subject has a systemic or metabolic disorder leading to progressive bone deterioration. 15. The subject is immunologically suppressed or receiving steroids in excess of normal physiological requirements. 16. The subject's bone stock in compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis. 17. The subject has had a knee fusion to the affected joint. 18. Female patients planning a pregnancy during the course of the study. 19. The patient is unable or unwilling to sign the Informed Consent specific to this study

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Region Skane

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Region Skane
    ClinicalTrials.gov Identifier:
    NCT04358601
    Other Study ID Numbers:
    • Allpoly Triathlon PS
    First Posted:
    Apr 24, 2020
    Last Update Posted:
    Sep 14, 2021
    Last Verified:
    Sep 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 14, 2021